Tumor Spectrum in Children With Noonan Syndrome and SOS1 or RAF1 Mutations
Date
2010Author
Vandecasseye, Willy
Fryns, Jean-Pierre
Sciot, Raf
Massa, Guy
Denayer, Ellen
Devriendt, Koen
de Ravel, Thomy
Van Buggenhout, Griet
Smeets, Eric
Francois, Inge
Sznajer, Yves
Craen, Margarita
Leventopoulos, George
Mutesa, Leon
Kayserili, Hulya
Legius, Eric
Metadata
Show full item recordAbstract
Noonan syndrome (NS) is an autosomal dominant disorder caused by mutations in PTPN11, KRAS, SOS1, and RAF1 We performed SOS1, RAF1, BRAF MEK1, and MEK2 mutation analysis in a cohort of 102 PTPN11- and KRAS-negative NS patients and found pathogenic SOS1 mutations in 10, RAF1 mutations in 4, and BRAF mutations in 2 patients. Three novel SOS1 mutations were found. One was classified as a rare benign variant and the other remains unclassified. We confirm a high prevalence of pulmonic stenosis and ectodermal abnormalities in SOS1-positive patients. Three patients with SOS1 mutations presented with tumors (embryonal rhabdomyosarcoma, Sertoli cell testis tumor, and granular cell tumors of the skin). One patient with a RAF1 mutation had a lesion suggestive for a giant cell tumor. This is the first report describing different tumor types in ISIS patients with germ line SOS1 mutations. (C) 2009 Wiley-Liss, Inc.
Collections
- Makale [92796]